Drug Type Small molecule drug |
Synonyms 3,5-dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha-2-diamine, Bromexine Hydrochloride, Bromhexine + [14] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1963), |
RegulationOrphan Drug (US) |
Molecular FormulaC14H21Br2ClN2 |
InChIKeyUCDKONUHZNTQPY-UHFFFAOYSA-N |
CAS Registry611-75-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01778 | Bromhexine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Bronchitis | JP | 29 Mar 1991 | |
Bronchitis, Chronic | JP | 29 Mar 1991 | |
Sputum excretion difficulty | JP | 01 Nov 1980 | |
Pneumoconiosis | JP | 01 Nov 1976 | |
Pulmonary Tuberculosis | JP | 01 Nov 1976 | |
Respiratory Tract Infections | - | - | 01 Jan 1963 |
Xerophthalmia | - | - | 01 Jan 1963 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute sinusitis | Phase 3 | CN | 06 Jul 2021 | |
Chronic bronchial disease | Phase 3 | CN | 06 Jul 2021 | |
Chronic sinusitis | Phase 3 | CN | 06 Jul 2021 | |
Lower Respiratory Tract Infections | Phase 3 | CN | 06 Jul 2021 | |
Tracheobronchitis | Phase 3 | CN | 06 Jul 2021 | |
Bronchiectasis | Phase 3 | CN | 07 Apr 2021 | |
Bronchopneumonia | Phase 3 | CN | 07 Apr 2021 |
Phase 4 | 50 | (Control Group) | hukadrxfry(kuaftlixnr) = fosqgivyex ebvquqeafx (xrrqzznptn, pruanmwesp - yccsrypusb) View more | - | 13 Apr 2022 | ||
(Bromhexine Hydrochloride Group) | rhcvudjmvr(abnfozavxm) = xjdudcepjy qkdbcdfrgx (rbrgsukqrw, goiprbpqbv - cmlipicipc) View more |